Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs bupivacaine + methylprednisolone in ultrasound-guided erector spinae plane block for postoperative pain after lumbar spine surgery
IRCT20210415050983N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in lumbar disc disease comparing Bupivacaine with Bupivacaine + methylprednisolone (2 arms). Primary endpoint: Postoperative pain intensity. Started May 2024; status: completed.
02
Drugs
bupivacainemethylprednisolone
03
Conditions
lumbar disc disease
Beyond the preview
Go deeper on IRCT20210415050983N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N6.